Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, ...
In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold a ...
Shares of Tempus AI (TEM) were up 33% to $46.85 in afternoon trading after the company announced the national launch of olivia earlier. Olivia is an AI-enabled personal health concierge app ...
Hosted on MSN20d
Tempus AI: A Game-Changer in AI-Powered HealthcareShares of Tempus AI Inc. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7.5 billion. The rally was driven by headline-grabbing news and strong market sentiment ...
In a report released today, Ryan MacDonald from Needham reiterated a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report), with a price target of $56.00. Discover outperforming stocks ...
Sabre (NASDAQ:SABR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses ...
Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. Yet, as we go through and discuss the setup here, I contend that investors ...
Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...
Tempus AI shares were up 14%, to $36.42, after the company launched its FDA-approved in vitro diagnostic device, xT CDx. The healthcare technology company said Wednesday that, beginning today, xT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results